XML 23 R11.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

SELECTED FINANCIAL STATEMENT INFORMATION | 6 Months Ended
--- | ---
Apr. 30, 2024
Selected Financial Statement Information [Abstract] |
Selected Financial Statement Information [Text Block] | SELECTED FINANCIAL STATEMENT INFORMATION Accounts Receivable
(in thousands) |  | April 30, 2024 |  | October 31, 2023
Accounts receivable |  | $517,633 |  |  | $521,696 |
Less: Allowance for doubtful accounts |  | (13,271) |  |  | (12,621) |
Accounts receivable, net |  | $504,362 |  |  | $509,075 |
Inventories
(in thousands) |  | April 30, 2024 |  | October 31, 2023
Finished products |  | $659,590 |  |  | $622,395 |
Work in process |  | 91,326 |  |  | 79,789 |
Materials, parts, assemblies and supplies |  | 337,185 |  |  | 311,496 |
Inventories, net of valuation reserves |  | $1,088,101 |  |  | $1,013,680 |
Property, Plant and Equipment
(in thousands) |  | April 30, 2024 |  | October 31, 2023
Land |  | $19,809 |  |  | $19,706 |
Buildings and improvements |  | 207,253 |  |  | 202,499 |
Machinery, equipment and tooling |  | 403,944 |  |  | 386,602 |
Construction in progress |  | 30,518 |  |  | 25,867 |
|  | 661,524 |  |  | 634,674 |
Less: Accumulated depreciation and amortization |  | (334,784) |  |  | (312,826) |
Property, plant and equipment, net |  | $326,740 |  |  | $321,848 |
Accrued Customer Rebates and Credits The aggregate amount of accrued customer rebates and credits included within accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets was $25.5 million as of April 30, 2024 and $24.5 million as of October 31, 2023. The total customer rebates and credits deducted within net sales for the six months ended April 30, 2024 and 2023 was $5.8 million and $4.2 million, respectively. The total customer rebates and credits deducted within net sales for the three months ended April 30, 2024 and 2023 was $2.3 million and $2.0 million, respectively. Research and Development Expenses The amount of new product research and development ("R&D") expenses included in cost of sales for the six and three months ended April 30, 2024 and 2023 is as follows (in thousands):
| Six months ended April 30, |  | Three months ended April 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
R&D expenses | $53,031 |  |  | $43,134 |  |  | $27,935 |  |  | $22,896 |
Redeemable Noncontrolling Interests The holders of equity interests in certain of the Company's subsidiaries have rights ("Put Rights") that may be exercised on varying dates causing the Company to purchase their equity interests through fiscal 2032. The Put Rights, all of which relate either to common shares or membership interests in limited liability companies, provide that the cash consideration to be paid for their equity interests (the "Redemption Amount") be at fair value or a formula that management intended to reasonably approximate fair value based solely on a multiple of future earnings over a measurement period. Management's estimate of the aggregate Redemption Amount of all Put Rights that the Company could be required to pay is as follows (in thousands):
| April 30, 2024 |  | October 31, 2023
Redeemable at fair value | $309,005 |  |  | $308,472 |
Redeemable based on a multiple of future earnings | 59,364 |  |  | 56,335 |
Redeemable noncontrolling interests | $368,369 |  |  | $364,807 |
During fiscal 2024, the holders of a 15% noncontrolling equity interest in a subsidiary of the ETG that was acquired in fiscal 2019 exercised their option to cause the Company to purchase their noncontrolling interest over a four-year period ending in fiscal 2027. Accordingly, the Company acquired one-fourth of such interest in March 2024, which increased the Company's ownership interest in the subsidiary to 88.75%. During fiscal 2022, the holder of a 19.9% noncontrolling equity interest in a subsidiary of the FSG that was acquired in fiscal 2015 exercised their option to cause the Company to purchase their noncontrolling interest over a four-year period ending in fiscal 2026. In December 2023, the Company acquired an additional one-fourth of such interest, which increased the Company's ownership interest in the subsidiary to 90.05%. Accumulated Other Comprehensive Loss Changes in the components of accumulated other comprehensive loss for the six months ended April 30, 2024 are as follows (in thousands):
| Foreign Currency Translation |  | Defined Benefit Pension Plan |  | Accumulated Other Comprehensive Loss
Balances as of October 31, 2023 | ($39,165) |  |  | ($1,015) |  |  | ($40,180) |
Unrealized gain | 4,477 |  |  | — |  |  | 4,477 |
Amortization of unrealized loss | — |  |  | 26 |  |  | 26 |
Balances as of April 30, 2024 | ($34,688) |  |  | ($989) |  |  | ($35,677) |

X
- References No definition available. + Details
Name: | hei_SelectedFinancialStatementInformationAbstract
Namespace Prefix: | hei_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration